Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients
Condition(s):Thalassemia, BetaLast Updated:December 1, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Thalassemia, BetaLast Updated:December 1, 2023Completed
Condition(s):Sickle Cell Disease; Sickle-Cell; Hemoglobin Disease, Thalassemia; Sickle Cell-beta-thalassemia; Sickle Cell Hemoglobin CLast Updated:February 11, 2022Completed
Condition(s):Glioma; GlioblastomaLast Updated:October 8, 2020Unknown status
Condition(s):Sickle Cell AnemiaLast Updated:December 12, 2014Completed
Condition(s):Anemia, Sickle Cell; Anemia; Sickle-Cell, With CrisisLast Updated:February 23, 2017Unknown status
Condition(s):Thalassemia IntermediaLast Updated:June 20, 2012Unknown status
Condition(s):Thalassemia, BetaLast Updated:September 20, 2017Unknown status
Condition(s):Sickle Cell Disease; Sickle Cell AnemiaLast Updated:March 13, 2023Recruiting
Condition(s):Sickle Cell Anemia; Sickle Cell Disease; MalariaLast Updated:December 4, 2018Completed
Condition(s):Sickle Cell Disease; StrokeLast Updated:December 28, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.